C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2001
12/13/2001	WO2001094596A1 Novel polypeptide - a human purine receptor 21.23 and polynucleotide encoding it
12/13/2001	WO2001094595A1 Novel polypeptide- a human octamer binding protein 15 and polynucleotide encoding it
12/13/2001	WO2001094594A1 Novel polypeptide - a human atp-dependent serine protease 12.2 and polynucleotide encoding it
12/13/2001	WO2001094593A1 A novel polypeptide - human glyceraldehyde-3-phosphate dehydrogenase 11 and the polynucleotide encoding said polypeptide
12/13/2001	WO2001094592A1 A novel polypeptide, a human aldehyde/ketone reductase 10.1 and the polynucleotide encoding the polypeptide
12/13/2001	WO2001094591A1 A novel polypeptide-glyceraldehyde-3-phosphate dehydrogenase 10 and the polynucleotide encoding said polypeptide
12/13/2001	WO2001094589A1 Recombinant proteins and dna encoding the same
12/13/2001	WO2001094588A2 Gene (cur) related to a curly phenotype in plants
12/13/2001	WO2001094587A2 Extracellular messengers
12/13/2001	WO2001094586A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
12/13/2001	WO2001094585A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
12/13/2001	WO2001094584A2 21784, a novel human calcium channel family member and uses thereof
12/13/2001	WO2001094583A2 Human transporter proteins and polynucleotides encoding the same
12/13/2001	WO2001094582A1 Novel g protein-coupled receptor protein and dna thereof
12/13/2001	WO2001094581A1 Tumour suppressor and uses thereof
12/13/2001	WO2001094580A1 Novel g-protein coupled receptor
12/13/2001	WO2001094579A1 A novel polypeptide- human gm2 activator protein 8.8 and the polynucleotide encoding said polypeptide
12/13/2001	WO2001094578A1 A novel polypeptide, a ubch5 protein 11.44 and the polynucleotide encoding the polypeptide
12/13/2001	WO2001094577A1 A novel polypeptide, a cobalamin binding protein 36 and the polynucleotide encoding the polypeptide
12/13/2001	WO2001094576A1 A novel polypeptide- human protein 10 containing characteristic sequence of replicative dna polymerase a family and the polynucleotide encoding said polypeptide
12/13/2001	WO2001094574A2 Method and apparatus for purifying nucleic acids
12/13/2001	WO2001094573A2 Processing of plasmid-containing fluids
12/13/2001	WO2001094572A1 Nucleic acid isolation
12/13/2001	WO2001094571A1 Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof
12/13/2001	WO2001094570A2 Transfection method
12/13/2001	WO2001094566A2 Human enzymes and polynucleotides encoding the same
12/13/2001	WO2001094565A2 FATTY ACID ELONGASE 3-KETOACYL CoA SYNTHASE POLYPEPTIDES
12/13/2001	WO2001094564A2 Cis-zeatin o-glcocyltransferase from zea mays
12/13/2001	WO2001094562A2 Cold sensitive mutant dna polymerases
12/13/2001	WO2001094561A2 The non-mevalonate isoprenoid pathway
12/13/2001	WO2001094559A1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
12/13/2001	WO2001094558A1 Plant translation methods and compositions related thereto
12/13/2001	WO2001094557A1 Human chemokine beta-10 mutant polypeptides
12/13/2001	WO2001094556A1 Method for conditionally immortalising cells and protein constructs therefor
12/13/2001	WO2001094551A2 Genetically modified t-cells, method for producing them and use thereof
12/13/2001	WO2001094550A2 Identification and use of molecular markers indicating cellular reprogramming
12/13/2001	WO2001094548A2 Hy2 family of bilin reductases
12/13/2001	WO2001094547A2 Molecular delivery vehicle for delivery of selected compounds to targets
12/13/2001	WO2001094544A2 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification
12/13/2001	WO2001094542A2 Algorithmic determination of connectrons
12/13/2001	WO2001094537A2 Novel polypeptide--human nadh ubiquinone oxidoreductase 21.89 and polynucleotide encoding it
12/13/2001	WO2001094529A2 A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide
12/13/2001	WO2001094420A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
12/13/2001	WO2001094418A2 Leader peptides for enhancing secretion of recombinant protein from a host cell
12/13/2001	WO2001094416A2 Human proteins and nucleic acids encoding same
12/13/2001	WO2001094415A2 Nuclear hormone receptor
12/13/2001	WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE
12/13/2001	WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
12/13/2001	WO2001094409A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer
12/13/2001	WO2001094408A1 Tyrosine kinase modulators
12/13/2001	WO2001094405A1 A new polypeptide- nerve synapse ion channel-associated chapsyn-110 and the polynucleotide encoding it
12/13/2001	WO2001094404A1 A new polypeptide- human l1 retroposon 22 and the polynucleotide encoding it
12/13/2001	WO2001094403A1 A new polypeptide- human transcriptional activation subunit 14 and the polynucleotide encoding it
12/13/2001	WO2001094402A1 A new polypeptide---human npat protein 12 and the polynucleotide encoding it
12/13/2001	WO2001094401A1 A new polypeptide-human npat protein 15 and the polynucleotide encoding it
12/13/2001	WO2001094400A2 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF
12/13/2001	WO2001094399A1 A novel polypeptide - homo synaptosome - associated protein 11.66 and polynucleotide encoding said polypeptide
12/13/2001	WO2001094398A1 A novel polypeptide-homo igf conjugated protein 10.45 and polynucleotide encoding said polypeptide
12/13/2001	WO2001094397A1 A novel polypeptide-zinc finger protein 79.46 and the polynucleotide encoding said polypeptide
12/13/2001	WO2001094396A1 A novel polypeptide - homo ccr4 associated protein 9 and polynucleotide encoding said polypeptide
12/13/2001	WO2001094395A1 A novel polypeptide, a human zinc finger protein 38 and the polynucleotide encoding the polypeptide
12/13/2001	WO2001094394A2 Plant ubiquitin promoter sequences and methods of use
12/13/2001	WO2001094393A2 Synthetic spider silk proteins and the expression thereof in transgenic plants
12/13/2001	WO2001094391A2 Intracellular signaling proteins
12/13/2001	WO2001094389A2 Zcys7: a member of the cystatin superfamily
12/13/2001	WO2001094388A2 Zcys6: a member of the cystatin superfamily
12/13/2001	WO2001094385A2 Human hm74-like g protein coupled receptor
12/13/2001	WO2001094383A2 Mutated furin polypeptides having improved characteristics
12/13/2001	WO2001094380A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/13/2001	WO2001094374A1 A novel peptide-human adhesion plaque kinase 23.43 and the polynucleotide coding this novel peptide
12/13/2001	WO2001094366A1 Methods for improving the sequence fidelity of synthetic double-stranded oligonucleotides
12/13/2001	WO2001094003A2 Method and apparatus for washing and drying pins in microarray spotting instruments
12/13/2001	WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/13/2001	WO2001093913A2 T cell receptor fusions and conjugates and methods of use thereof
12/13/2001	WO2001093905A1 Immunostimulatory oligodeoxynucleotides
12/13/2001	WO2001093903A1 Antigenic composition comprising a polycationic peptide and inosine and cytosine
12/13/2001	WO2001093902A2 Immunostimulatory rna/dna hybrid molecules
12/13/2001	WO2001093901A1 Combined preparation for the treatment of neoplasic diseases
12/13/2001	WO2001093892A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury
12/13/2001	WO2001093851A2 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
12/13/2001	WO2001093836A2 Encapsulation of polynucleotides and drugs into targeted liposomes
12/13/2001	WO2001093835A1 Delivery systems for bioactive agents
12/13/2001	WO2001093805A2 FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS
12/13/2001	WO2001093669A2 Compound screens relating to insulin deficiency or insulin resistance
12/13/2001	WO2001072772A3 Calcium binding regulatory subunit
12/13/2001	WO2001070968A3 Production of recombinant blood clotting factors in human cell lines
12/13/2001	WO2001068147A3 Synthetic oligonucleotides as inducers of erythroid differentiation
12/13/2001	WO2001064023B1 Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection
12/13/2001	WO2001059086A3 Methods and constructs for agrobacterium-mediated plant transformation
12/13/2001	WO2001055325A8 Nucleic acids, proteins, and antibodies
12/13/2001	WO2001055206A8 Nucleic acids, proteins, and antibodies
12/13/2001	WO2001055205A8 Nucleic acids, proteins, and antibodies
12/13/2001	WO2001055103A3 Chimeric neuropeptide y receptors
12/13/2001	WO2001053502A3 Root-preferred promoter elements and methods of use
12/13/2001	WO2001046423A3 Npr1-interactors and methods of use
12/13/2001	WO2001046408A3 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/13/2001	WO2001045735A3 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
12/13/2001	WO2001044445A3 Human lyases and associated proteins
12/13/2001	WO2001043694A3 Compositions and methods for caspase-induced apoptosis
12/13/2001	WO2001042495A3 Products comprising a support whereon are fixed nucleic acids and their use as dna chip

1 ... 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 ... 4023